12 analysts have expressed a variety of opinions on Legend Biotech (NASDAQ:LEGN) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 7 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 4 | 1 | 0 | 0 | 0 |
| 2M Ago | 1 | 4 | 0 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
Analysts have recently evaluated Legend Biotech and provided 12-month price targets. The average target is $84.25, accompanied by a high estimate of $94.00 and a low estimate of $65.00. Marking an increase of 8.01%, the current average surpasses the previous average price target of $78.00.
Diving into Analyst Ratings: An In-Depth Exploration
The perception...
Login or create a forever free account to read this news
Sign up/Log in